Business Wire

QUECTEL-WIRELESS

26.6.2024 13:01:27 CEST | Business Wire | Press release

Share
Quectel Unveils FLM263D Wi-Fi Module: Pioneering Seamless Connectivity with ACK SDK for Matter

Quectel Wireless Solutions, a global IoT solutions provider, announced the launch of the FLM263D standalone Wi-Fi module that supports Alexa Connect Kit (ACK) SDK for Matter, enabling IoT devices to connect seamlessly with Matter compliant controllers including Amazon Alexa, Google Home, Samsung SmartThings, and Apple HomeKit.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240626747648/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Quectel unveils FLM263D Wi-Fi module: Pioneering seamless connectivity with ACK SDK for Matter (Photo: Business Wire)

Matter stands as a pivotal standard in smart home communication, tackling the persistent challenges of compatibility and fragmentation within the sector by enabling direct communication between smart devices. Governed by the Connectivity Standards Alliance (CSA), Matter devices undergo a stringent certification process to ensure secure, reliable, and universally interoperable connections. Adherence to this certification is paramount for all Matter-compliant products, fostering a unified communication framework and enhancing user experiences.

“We created ACK to make it simpler for device makers to build smart home devices with a fully-managed service without having deep expertise in multiple wireless protocols, complex cloud connectivity, and the necessary maintenance of cloud infrastructure. We are excited about this launch because Quectel’s FLM263D adds to ACK's portfolio of available solutions and offers more choices for device makers,” says Ben McInnis, Director, Smart Home, Amazon.

“Revolutionizing connectivity in the smart home landscape, our latest FLM263D module sets a new standard for seamless integration,” commented Norbert Muhrer, President and CSO, Quectel Wireless Solutions. “It also empowers developers with robust support for the ACK SDK for Matter, ensuring unparalleled interoperability and innovation in the IoT ecosystem.”

The FLM263D module is a 2.4GHz single band Wi-Fi 6 module, featuring a high-performance processor with a frequency of up to 320MHz. This innovative module boasts support for IEEE 802.11b/g/n/ax protocol and BLE 5.2, paired with built-in 512KB SRAM and 4MB flash for optimal performance. Furthermore, it meets rigorous security standards, including secure boot and mbed TLS encryption, ensuring robust protection for connected devices.

The FLM263D offers support for device certifications such as Works with Alexa (WWA) and features such as Matter Simple Setup (MSS). MSS allows end-users to seamlessly connect Matter-compliant smart home devices to Alexa with zero-touch setup, while WWA instils consumer confidence when buying on Amazon.

FLM263D offers five GPIO interfaces that can alternatively function as PWM or I2C communication channels. Designed with an LCC form factor, built-in PCB antenna, measuring a mere 17.3mm × 15.0mm × 2.8mm, and with an operating temperature range of -40°C to +105°C, 3.0~3.6V power supply, the FLM263D is perfectly suited for smart lighting applications, especially smart bulbs.

Additional modules will be rolled out very soon to expand the scope of Quectel offerings to include smart switches, smart plugs, and other smart household applications.

About Quectel

Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of 5,900 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules as well as antennas and services.

With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.

For more information, please visit: www.quectel.com, LinkedIn, Facebook, and X.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240626747648/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IQM and Deutsche Bahn Demonstrate Quantum Algorithm for Railway Scheduling on Real Operational Data20.7.2026 08:00:00 CEST | Press release

A hybrid quantum-classical algorithm, executed end to end on IQM hardware, produced feasible schedules with Deutsche Bahn, the German rail operator, using a real operational dataset of 190 trips across five German cities. The approach runs on today’s hardware and is designed to improve automatically as quantum processors scale, offering enterprises a model for extracting value now, ahead of fault-tolerant computing. The collaboration reflects IQM’s push into enterprise adoption. The company has sold 24 quantum computers worldwide and listed on the Nasdaq Global Select Market and Nasdaq Helsinki in July 2026 under the ticker IQMX. IQM Quantum Computers (Nasdaq: IQMX), a global leader in full-stack superconducting quantum computers, today published the results of a research collaboration with Deutsche Bahn, Europe’s largest rail operator, exploring how quantum computing can improve railway scheduling. This press release features multimedia. View the full release here: https://www.busines

Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region20.7.2026 07:00:00 CEST | Press release

Galderma launches Alastin, its premium regenerative skincare brand into Japan, Singapore, South Korea and Taiwan The Japan and Asia Pacific (JPAC) region is among the fastest‑growing markets globally for medical aesthetics and dermatological skincare, driven by rising adoption of minimally invasive procedures and an increased focus on skin quality, which are accelerating demand for innovative, science‑based skincare solutions such as Alastin1,2 These launches reflect Galderma’s ongoing growth across the JPAC region and long‑term commitment to advancing regenerative skincare Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of Alastin – its premium regenerative skincare brand – across the JPAC region. The brand recently launched in Taiwan, will soon launch in Japan, and has received approval to launch in Singapore and South Korea, with planned market introduction in September and November, respectively. This expansion follows Alastin’s recent la

Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers17.7.2026 19:10:00 CEST | Press release

Rapid oral presentations will highlight new Phase 1 data across Incyte’s solid tumor portfolioBoth INCB161734, an investigational, potent, selective and orally bioavailable KRAS G12D inhibitor, and INCA338901, a TGFβR2×PD-1 bispecific antibody, are being evaluated in ongoing Phase 3 programs as first-line treatments for patients with advanced pancreatic ductal adenocarcinoma (PDAC) and microsatellite stable (MSS) colorectal cancer, respectively Incyte (Nasdaq:INCY) today announced that it will highlight data from several programs in its oncology portfolio in six presentations at the European Society of Medical Oncology (ESMO) Congress 2026, being held October 23 - 27, 2026, in Madrid. “The data at ESMO will further illustrate Incyte’s commitment to advancing innovation for patients with cancer,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Among the presentations are important updates from our KRAS G12D inhibitor in advanced pancreatic ca

STL Expands Its Optical Connectivity Portfolio in the US with the CONCAT Solution17.7.2026 14:24:00 CEST | Press release

STL Optical Connectivity NA, LLC, (STLOC), a U.S. subsidiary of STL (Sterlite Technologies Ltd.) [NSE: STLTECH], a leading connectivity solutions provider for AI-ready digital infrastructure, today announced that it launched its new advanced FTTH solution, CONCAT, after successfully completing field trials on the networks of one of the largest telecom service providers in the United States. Following successful field validation, CONCAT is now available to digital infrastructure providers seeking faster fiber rollouts with reduced deployment complexity and labor. It enables up to 71% in labor cost savings by eliminating most field splicing through factory-assembled, pre-connectorized fiber segments that deliver plug-and-play installation. CONCAT simplifies fiber deployment by shifting critical fiber preparation and termination into a controlled manufacturing environment ensuring consistent quality, faster installation, and lower operational risk in the field. CONCAT solution is ideal fo

Aqemia and Sanofi Expand Their Research Collaboration17.7.2026 12:30:00 CEST | Press release

A new target nomination and a milestone payment mark the next step of the multi-year partnership first announced in December 2023 Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment. The collaboration, first announced in December 2023, makes Aqemia eligible to receive up to a total of $140 million in upfront and milestone payments across programs. It spans the drug discovery journey from the identification of the very first hits to the selection of a development candidate. Aqemia leverages Qemi, its proprietary physics-based generative AI platform, to design novel molecules addressing Sanofi’s targets of choice, working in close collaboration with Sanofi scientific teams. Sanofi leads wet lab research, devel

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye